Delivery Order SPE2DB22D2006-SPE2DB25FV6MD

Award Date 11/22/24
Potential Completion Date 11/25/24
Potential Value $8.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $26,845.14 Firm Fixed Price Delivery Order is for the supply of Sumatriptan Succinate 25 mg tablets, a medication used to treat migraine headaches. The award has a completion date of July 26, 2024 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant...
This federal contract award was issued by the Medical Supply Chain division of the U.S. Defense Department's Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The $10,552.64 firm fixed-price delivery order is for the supply of Sumatriptan Succinate 25 mg tablets, a common prescription medication used to treat migraines. The award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,640.70 firm fixed-price delivery order is for the supply of SUMATRIPTAN 6 MG/0.5ML AUTOINJ 0.5ML, a migraine medication. The contract has an ultimate completion date of March 17, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor in the United States. The $5,769.89 firm-fixed-price delivery order is for the supply of 4,565,716,916 units of 25 milligram Sumatriptan Succinate tablets. The award has an ultimate completion date of September 9, 2024. AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs) with the DLA Troop Support Medical and the Department of Justice...
This federal contract award, valued at $2,989.07, was issued by the Defense Logistics Agency's (DLA) Medical Supply Chain to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4566121544 - Sumatriptan 6 mg/0.5ml autoinjector, a migraine medication. The contract is a Firm Fixed Price Delivery Order with a period of performance through October 17, 2024. The award was made on October 16, 2024, and there was no...
This federal contract award, with an ID of SPE2DX15D6028|SPE2DX23FWUGU, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,710.72 firm fixed-price delivery order is for Sumatriptan Succinate 50mg tablets, a migraine medication. The contract has an ultimate completion date of September 12, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,148.22 firm-fixed-price delivery order is for the supply of sumatriptan 6 mg/0.5 ml cartridges, a medication used to treat migraines. The award does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,044.80 firm fixed-price delivery order contract covers the supply of Sumatriptan 6 mg/0.5 ml autoinjectors, a prescription medication used to treat migraine headaches. The contract has an ultimate completion date of January 13, 2025 and does not have a set-aside designation, indicating open competition....
This federal contract award, valued at $33,241.99, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a Delivery Order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support...
This federal contract award, with ID SPE2DB20D3103|SPE2DB24FP7E0, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,600.12 fixed-price delivery order covers the provision of sumatriptan succinate 25 mg tablets, a medication used to treat migraines. The contract has an ultimate completion date of August 1, 2024 and was awarded on July 31, 2024. It is not designated as a set-aside contract....
  • SPE2DB22D2006
    Indefinite Delivery Contract
  • SPE2DB22D2006-SPE2DB25FV6MD
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,806.28 firm-fixed-price delivery order is for the supply of 9-count bottles of 25mg Sumatriptan succinate tablets, a common migraine medication. The contract has an ultimate completion date of November 25, 2024.

AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies for military personnel, veterans, and other federal beneficiaries.

Generated 5/20/25, 2:11 PM